Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
49
NCT02972450
An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Phase: Phase 1/2
Role: Collaborator
Start: Feb 20, 2019
Completion: Jul 11, 2019
NCT06432166
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients
Role: Lead Sponsor
Start: Sep 1, 2025
Completion: Dec 31, 2028